Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Elsevier adds 43 million Enamine make-on-demand compounds to Reaxys to accelerate chemistry R&D

Contributed by: Agility PR Solutions

Logo

Agility PR Solutions logo

Tags

Elsevier
Reaxys

More Like This

Business Wire logo

Enamine and BioSolveIT Embark on Exclusive Partnership

PR Newswire associated0

Elsevier introduces Reaxys AI Search, enabling faster and more accessible chemistry research through natural language discovery

Elsevier and Iktos logos

Elsevier and Iktos partner to deliver an AI-driven synthetic chemistry platform for drug discovery

PR Newswire associated0

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

Business Wire logo

Advanced Manufacturing, Global Reach, and Streamlined Services — Asymchem Impresses at CPHI Milan 2024

Tres Alchemix Co. Ltd.

Tres Alchemix Closes $4.4 Million Series A To Advance AI Drug-Design Platform

PR Newswire associated0

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

ACCESSWIRE associated3

ChemPartner Unveils Highly Anticipated Biology Database

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us